Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
  1. 8-K Event Other events
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Other events
  4. EFFECT Other Notice of Effectiveness
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. 4 Open-market sale Chief Financial Officer sold 2,015 shares at $12.45 ($25,090)
  8. 4 Open-market sale See Remarks sold 1,672 shares at $12.45 ($20,813)
  9. 4 Open-market sale See Remarks sold 5,706 shares at $12.46 ($71,082)
  10. 4 Open-market sale Chief Operating Officer sold 1,115 shares at $12.46 ($13,890)
  11. S-3 Offering Registration Statement
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Regulation FD disclosure
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 20 · 383 filings